Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.206
-0.004 (-1.82%)
Nov 21, 2024, 11:39 AM EST - Market open
Bionano Genomics Employees
Bionano Genomics had 344 employees as of December 31, 2023. The number of employees decreased by 61 or -15.06% compared to the previous year.
Employees
344
Change (1Y)
-61
Growth (1Y)
-15.06%
Revenue / Employee
$96,901
Profits / Employee
-$394,718
Market Cap
19.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
Bolt Biotherapeutics | 100 |
Enlivex Therapeutics | 71 |
Apollomics | 45 |
NeurAxis | 19 |
Tempest Therapeutics | 17 |
NeuroOne Medical Technologies | 16 |
XTL Biopharmaceuticals | 7 |
BNGO News
- 7 days ago - Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 17 days ago - Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - GlobeNewsWire
- 20 days ago - Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 21 days ago - Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - GlobeNewsWire
- 6 weeks ago - Bionano Announces Preliminary 3Q 2024 Revenues and Cash - GlobeNewsWire
- 3 months ago - Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript) - Seeking Alpha
- 3 months ago - Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript - Seeking Alpha